Type 1 indicates the processes of β-cell destruction that may ultimately lead to diabetes in which insulin is required for survival in order to prevent the development of ketoacidosis, coma, and death.
Read More »Dr. Richard Bergman, Part 3 – Predicting Type 2 Diabetes
Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman, founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles, discuss the ability to predict the development of type 2 diabetes and the role A1c might play in this prediction.
Read More »Testosterone Increasing Insulin Sensitivity
A known link between low testosterone levels and decreased insulin sensitivity could lead to a treatment for men with type 2.
Read More »Assessing the Latest Information on SGLT-2 Inhibitors and Ketoacidosis
To maintain the benefits while minimizing risk, consider patient risk factors when prescribing, and monitor for DKA and UTI.
Read More »Reducing Diabetes by Reducing Fat From the Pancreas
Study finds insulin secretion returns to normal with one-gram fat loss.
Read More »Extremely Low Calorie Diet May Reverse Diabetes
Study suggests extreme calorie reduction may have same effect as bariatric surgery.
Read More »With Diabetes, Symptoms Are Not Always as Expected
Male, 72 years of age, type 2, insulin requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of work day, glucose elevated much higher than he reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy, leukocyte esterase 2+, wbc >60 H, bacteria many (>50) H, RBC 3-10, H.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #1: Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance Part 1 of 6
A critical requirement for orderly epidemiologic, genetic and clinical research, and indeed for the management of diabetes mellitus and other forms of glucose intolerance is an appropriate classification system. Furthermore, a hallmark in the process of understanding the etiology of a disease and studying its natural history is the ability to identify and differentiate its various forms and place them into a rational etiopathologic framework.
Read More »Dr. Richard Bergman, Part 2 – Insulin Resistance Risk Factors
Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association's 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.
Read More »Nordic Food Associated with Lowering Risk of Type 2 Diabetes
Diet containing foods high in antioxidants found to reduce risk of stroke.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.